Head-to-head · WeighScore
Mondae vs Sunlight.com
The verdict
Sunlight.com takes it — 85.4/100 to 74.3/100.
Sunlight.com grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the cheapest published rates in the ranking — semaglutide $88/mo, tirzepatide $157/mo, flat and stated never to rise — from a LegitScript-certified telehealth with two named, NPI-verified physicians.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Mondae | Sunlight.com |
|---|---|---|
| WeighScore | 74.3/100 | 85.4/100 |
| Grade | C | B |
| Scorecard rank | #68 | #7 |
| Semaglutide | $87 per 28 days (thirteen charges a year; $75/mo requires a three-month prepay) | $88/mo |
| Tirzepatide | $126 per 28 days (thirteen charges a year; $124/mo requires a three-month prepay) | $157/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #68 · C
Strengths
- $87 and $126 per cycle are at the low end of what this ranking records for either molecule
- No membership or consultation fee is charged, stated on the checkout itself rather than in marketing copy
- Free shipping, and support hours are published as 8:00 AM to 8:00 PM Eastern
- A priced injectable peptide menu sits beside the GLP-1 lines
Where it loses points
- A Mondae month is 28 days — the intake says shipped and billed every 28 days, which is thirteen charges a year
- The homepage figures “from $75” and “from $124” are three-month prepay rates; the month-to-month rates are $87 and $126
- The hero reads “prices start from $87” above a grid whose lowest figure is $63
- The peptide rows are labeled billed monthly under three-month rates
- A pharmacy, Greenwich, is named on the sermorelin, NAD+ and glutathione pages and on neither GLP-1 page — the compounder for the drug this row is about is not disclosed
- No clinician, medical group or NPI is named; the Terms name a telehealth platform only
- Shipping is quoted at about two days in the plan FAQ and five to seven business days in the shipping policy
Graded #7 · B
Strengths
- Cheapest published semaglutide in this ranking ($88/mo) with competitively priced tirzepatide ($157/mo), both flat and stated to never increase — not quiz-gated, the FAQ states the exact figures
- LegitScript-certified with two named physicians and public NPI numbers (Lion MD network), rather than an anonymous "licensed clinicians" claim
- No membership fee, cancel anytime, free shipping in 1-2 days, a fresh 4-week supply every month
- All 50 states served, plus a separate live NAD+ program on the same domain
Where it loses points
- Injection only — the hero banner's "Injections and oral options available" line does not match the live site: no oral GLP-1 product page exists and sunlight.com/oral-semaglutide/ 404s
- The $157 tirzepatide figure sits inside a collapsed FAQ accordion rather than the hero, so it takes one extra click to find even though it is genuinely on the page
- Sermorelin is marketed as "launching soon" and is not yet live — do not expect it today
- No published lab or monitoring cadence, and the compounding pharmacy partner is referenced only generically, not named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.